To check effect of intrauterine and sublingual and per rectal misoprostol in C-section for blood loss during and after delivery .

To evaluate efficacy of intrauterine and sublingual and per rectal misoprostol during cesarean section in controlling postpartum haemorrhage. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094276

Enrollment

147

Registered

2025-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Misoprostol: 600mcg misoprostol in caesarean section in controlling postpartum haemorrhage by intrauterine/sublingual/per rectal routes Control Intervention1: intrauterine, sublingual a

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant women undergoing caesarean section

Exclusion criteria

Exclusion criteria: Women with pre-existing coagulopathies, uterine anomalies, or known hypersensitivity to prostaglandins. Patients with known as asthma, cardiac disease, acute angle closure glaucoma .Traumatic postpartum hemorrhage during caesarean section.Scar rupture Angle extension.Uterine artery cut.Scar dehiscence.

Design outcomes

Primary

Measure	Time frame
Intraoperative and postoperative blood lossTimepoint: During c section after placenta out and for next 48hrs post delivery	—

Secondary

Measure	Time frame
Need for blood transfusionTimepoint: Upto 48hrs post operative	—

Countries

India

Contacts

Public ContactDrHarvir Kaur

Adesh university

drmbsandhu@gmail.com8198884222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026